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Distribution, Metabolism, and Excretion
of Di-2-ethylhexyl Phthalate in the Rat*
by Carl 0. Schulzt and Robert J. Rubin
It has become increasingly evident in re-
cent years that the dialkyl phthalate esters
are widely distributed in our environment
(1-4). As an explanation of this wide dis-
tribution there are many possible pathways
by which these chemicals can be introduced
into the human body. Jaeger and Rubin (5)
have shown that di-2-ethylhexyl phthalate
(DEHP) can be found in the tissues of pa-
tients who have received transfusions of
blood stored in plastic bags. Moreover, the
possibility of introducing significant
quantities of phthalate esters to the system
through ingestion of foodstuffs contami-
nated with these materials cannot be
ignored. In order more fully to understand
the toxicological implications of phthalate
ester contamination, it is important to deter-
mine the fate of these materials once they
are within the body. The study described
here was undertaken in order to ascertain
the distribution, metabolism, and elimination
of DEHP administered to rats.
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Materials and Methods
Materials
Di-2-ethylhexyl phthalate (DEHP) labeled
with carbon-14 at the carbonyl carbon was
obtained from American Radiochemicals
Corporation, Sanford, Florida. Unlabeled
DEHP was provided by the Monsanto Com-
pany, St. Louis, Missouri. The rats used in
this study were adult (150-250 g) male
CFN rats from Carworth Farms, Inc., New
York, New York. Radioactivity assays were
performed by using a Packard Tri-Carb
Model 3200 scintillation spectrometer.
Thin-layer chromatographs were run on
Brinkman silica gel G-25 UV254 plates.
Procedure
Labeled DEHP was prepared for intra-
venous injection by dissolving labeled and
unlabeled DEHP in hexane. An appropriate
amount of this hexane solution was trans-
ferred to a glass rosette vessel, and the
hexane solvent was removed by evaporation.
The volume was made up to 10 ml with a
solution of 4% bovine serum albumin in
0.9% aqueous sodium chloride. The mixture
was then probe sonicated for 10 min with a
Branson sonifier using the microprobe tip.
Stability of the resulting solution or emul-
sion was monitored by assaying aliquots for
homogeneous dispersion of the radioactivity
using the scintillation spectrometer. Two
different injection mixtures were prepared
by this method. The preparation used for
January 1973 123the low dose contained 0.02 mg DEHP/ml
and 5 MCi/ml. This preparation, following
sonication, was clear and thus presumably
represents a true solution. It was injected via
the dorsal penis vein otn the basis of 5 ml/kg
of body weight, resulting in a dose of 0.1
mg DFHP/kg. The preparation use(d for t'he
hligh dose contained 40 mng DEHP/ml and 5
(Ci/ml. Sonication of this preparation
resulted in a milky emulsion. Administration
of 5 ml of this emulsion/kg of body weight
resulted in a dosage of 200 mg DEHP/kg of
body weight.
For oral administration, DEHP was pre-
pared in corn oil at a concentration of 40
mg/ml. Intubation of 5 ml/kg of body
weight resulted in an oral dose of 200
mg/kg.
After administration of the dose, the
animals were housed in metabolism cages so
that the urine and feces could be collected.
The rats were allowed free access to food
and water. Blood samples were taken from
the tail artery. After 1 or 24 hr, the animals
were sacrificed by decapitation and were
dissected. Any urine remaining in the uri-
nary bladder was withdrawn with a syringe
and combined with the collected urine. The
blood, urine, feces, and tissues were then
analyzed according to the scheme outlined
in Figure 1. Subsequernt treatment of the
aqueous phase with chloroform-methanol
extracted no additional radioactivity. in-
dicating that the first extraction step was
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FIGURE 1. Analytical scheme for the determina-
tion of radioactivity of tissue samples from- rats.
complete and that any residual radioactivity
is associated with a water-soluble material.
Thin-layer chromatograms were developed
by uising a 65:25:4 (v/v/v) mixture of
chloroform, methanol, and water. The devel-
oped plates were visualized under ultraviolet
light. Distribution of radioactivity was deter-
mined by scraping and collecting 0.5-cm
wide strips of the silica gel, progressing
vertically from the origin to the solvent
front. The scrapings were individually
analyzed for radioactivity in the scintillation
spectrometer.
Results and Discussion
The very rapid logarithmic disappearance
of organic extractable radioactivity from the
bloodstream, which is assumed to corre-
spond to the disappearance of unchanged
DEHP, is shown in Figure 2. The dis-
appearance appears to be biphasic. The
initial rapid phase corresponds to a half-time
of 9.0 min for unchanged DEHP and con-
tinues for about 30 mm. Thus, after 30 min,
less than 15% of the material initially
present in the blood is still present in the
bloodstream. The second, less rapid phase
corresponds to a half-time of 22 min. Such
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1Environmental Health Perspectives 124biphasic behavior is not unusual and results
from two processes having different rate
constants.
Figure 3 shows the time course of dis-
appearance of organic extractable
radioactivity in the blood of rats receiving
the low dose (0.1 mg/kg) of DEHP intra-
venously. It will be noted that the initial
rate of disappearance is even faster at the
low dose than at the high dose (til = 4.5
min). The rapid initial rates of disappearance
at both doses and the more rapid rate at the
low dose strongly suggest a selective uptake
of DEHP by some tissue compartment with
saturation of that uptake process occurring
at the larger dose. The slower, second phase
of disappearance of the low dose from the
blood is represented by a dashed line in
Figure 3, since there are insufficient data to
determine the actual slope. The slope of the
dashed line is the same as that for the slow
phase of disappearance at the high dose.
Whether this assumption is valid or not, it is
clear that the 60 min data lie on a slope
distinctly different from the initial slope.
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FIGURE 3. Kinetics of DEHP disappearance from
the blood of rats following a 0.1 mg/kg intra-
venous dose.
Figure 4 shows the buildup of a small but
significant amount of water-soluble radio-
active label in the bloodstream after adminis-
tration of either dose. This buildup is
consistent with the hypothesis that the
water-soluble material is a metabolite or
metabolites of DEHP.
Additional support for the concept of
accumulation of DEHP at specific locations
against a concentration gradient is given
by calculating apparent volumes of distri-
bution Vd. Fifteen minutes after injection
of the low dose, before metabolism and
excretion have become significant, the Vd is
341 ml, well in excess of the volume of
total body water.
Figure 5 shows the distribution of radio-
active label among tissues and excretory
products 1 and 24 hr after the intravenous
injection of 200 mg DEHP/kg. At 1 hr,
71.4% of the injected dose was recovered in
the organic extractable fraction and another
8.0% in a water-soluble form. With regard to
tissue localization, approximately 50% of the
injected dose was found in the liver after 1
hr. This observation is consistent with a site
of selective uptake of DEHP suggested by
the kinetics of its disappearance from blood.
The only other organs, in addition to the
carcass, which contain significant levels of
organic extractable label after 1 hr are those
organs of known reticuloendothelial function
(i.e., the spleen and lungs). The presence of
significant levels of organic extractable mate-
rial in the large intestine (including the
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FIGURE 4. Appearance of water-soluble derivatives
of DEHP in the blood: (-) 0.1 mg/kg intraven-
ous dose; (--) 200 mg/kg intravenous dose.
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FIGURE 5. Tissue distribution of DEHP as percentage of the injected dose: (O3) 1 hr and (H) 24 hr after
administration of a 200 mg/kg intravenous dose. Flat bars represent trace amounts (less than 0.1% of the
injected dose).
contents) indicates that unchanged DEHP
might enter the gastrointestinal tract by
some secretory process, presumably biliary.
The 8.0% of the total injected dose that is
found in the water-soluble form after 1 hr is
distributed primarily in the liver, the intes-
tinal contents, and the urine. These data
suggest that the liver is the site of the
metabolism of the original DEHP to a
water-soluble form and that this metabolite
is rapidly excreted into the gastrointestinal
tract and the urine. This suggestion is fur-
ther strengthened by the distribution of the
radioactivity after 24 hr. At this time, 54.6%
of the total injected dose can be recovered
in the water-soluble fraction, primarily in
the intestinal contents, excreted feces, and
the urine, while only 20.5% of the dose can
be recovered in the organic extractable form.
It is interesting to note that over the 24-hr
period, the organic extractable radioactivity
fell in all organs and increased in the large
intestine, feces, and urine, thus indicating
biliary and renal excretion as additional
routes of elimination of DEHP.
Earlier experiments in our laboratory
using emulsions prepared with a less power-
ful sonicator indicated that one third of the
injected dose (200 mg/kg) was retained as
unchanged DEHP in the lungs after
twenty-four hours. These animals continued
to exhibit significant quantities of DEHP in
their lungs up to 24 days after injection.
Since the present studies show only 0.3% of
the injected dose in the lungs after 24 hr, it
is clear that the particle size of the DEHP in
the injection medium is critical for its distri-
bution within the body.
The distribution of label 1 hr after an
intravenous injection of a 0.1 mg/kg dose
and of a 200 mg/kg dose is compared in
Figure 6. Qualitatively, the distribution of
label among the tissues is similar at the low
ORGANIC
EXTRACTABLE
% of
DOSE
WATER
SOLUBLE
% of
DOSE
50
40
30
20-
lo[
25 -
20 -
15
O -
LIVER
El 200 mg/kg IV: SUM =71.4%
EO 0.1 mg/kg IV: SUM=55.8%
0l 200mg/kg V: SUM = 8.0 %
0 0.1 mg/kg IV SUM =25.7 %
CARCASS SPLEEN URINE
FIGURE 6. Comparison of the tissue distribution
of two different intravenous doses of DEHP 1 hr
after injection: (03) 200 mg/kg dose; (U) 0.1
mg/kg dose. Flat bars represent trace amounts
(less than 0.1% of the injected dose).
Environmental Health Perspectives 126dose to that for the higher dose. However,
the percentage of the injected dose re-
covered as unchanged DEHP is slightly lower
at each site for the lower dose and totals
only 55.8% as compared to 71.4% un-
changed at the higher dose. The most
striking difference is that, whereas after 1 hr
only 8% of the higher dose has been con-
verted to water-soluble metabolite, 25% of
the lower dose has undergone this conver-
sion. These results apparently reflect
saturation of the metabolic mechanism by
the higher dose, with the result that a corre-
spondingly smaller percentage of the higher
dose is metabolized.
In Figure 7 is shown the distribution data
from rats given the low dose of DEHP. At
this dose level essentially all the injected
material has been converted to water-soluble
metabolites and excreted in the urine and
feces after 24 hr. Only a small percentage
(1-2%) of the original dose remains in the
body under these conditions.
The results of oral administration of
DEHP in corn oil by gastric intubation are
summarized in Table 1. It can be seen in the
lower portion of Table 1 that approximately
80% of the intubated dose can be recovered
after 24 hr. Of this, 61.7% was found in the
water-soluble fraction, either excreted in the
urine and feces or in the large intestine,
presumably in the fecal material. The re-
maining 12.8% was found as organic-soluble
DEHP, and once again, in the excreta. It is
important to note that negligible radio-
activity was found in all organs assayed.
In the light of this extensive metabolism
of an oral dose of DEHP, it is interesting to
note the extremely small amounts of radio-
activity that appear in the blood following
the oral intubation. The data are presented
here as disintegrations per minute per milli-
liter (dpm/ml) of the whole blood and their
magnitude should be compared to the 3.337
x 106 dpm of DEHP administered. It is also
interesting that, in spite of the low levels of
radioactivity recovered in the blood, the
level of water-soluble radioactivity at each
time point is greater than the
organic-extractable. These results indicate
that the metabolism of DEHP is extensive
and that the rate of metabolism is more
rapid than the rate at which it is absorbed
from the gastrointestinal tract.
In order to understand the nature of the
metabolism of DEHP more fully, attempts
have been made to isolate and characterize
the water-soluble labeled material in the
feces and urine from the experimental
animals. It has been found that if the aque-
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FIGURE 7. Tissue distribution of DEHP 24 hr after administration of a 0.1 mg/kg intravenous dose. Flat bars
represent trace amounts (less than 0.1% of the injected dose).
January 1973 127Table 1. Absorption and distribution of an
oral dose of 200 mg/kg of DEHP in corn
oil administered by gastric intubation.
Distribution, % of
Blood level, dpm/mla administered dose
Time,
hr Site Organic Aqueous Organic Aqueous
I Blood 20 577
3 Blood 76 752
5 Blood 54 811
24 Blood 10 218
24 Urine 0.3 33.9
24 Feces 9.9 13.0
24 Large intestine 2.5 14.6 and contents
24 Small intestine 0.1 0.2
and contents
24 All other organs Negligible Negligible
24 Total 12.8 61.7
a3.337 x 106 dpm administered in corn oil.
ous layer resulting from the extraction of
urine or feces is acidified to pH < 1 with
concentrated hydrochloric acid, more than
95% of the labeled material can then be
extracted from the aqueous phase by using
chloroform. This behavior is consistent with
the presence of an ionizable functional
group in the water-soluble material. When
the chloroform extract was concentrated and
analyzed by thin-layer chromatography there
was a complex array of spots distributed
from the origin to the solvent front. How-
ever, an analysis of the distribution of radio-
activity on the plate gave a pattern like that
shown in Figure 8. It is clear from this
figure that there are at least four different
major metabolites. The spots at the top of
the figure represent the relative mobilities of
phthalic acid, 2-ethylhexyl acid phthalate
(the monoester of DEHP), and DEHP. The
lack of correspondence of any of these
markers with the radioactive spots indicates
that metabolism is not a simple stepwise
hydrolysis of the diester. Comparable
thin-layer chromatograms of nonfractionated
urine were not substantially different from
those of the chloroform extract. The same is
true of urine collected directly from the
urinary bladder of rats 1 hr after adminis-
tration of the DEHP, eliminating the possi-
bility of microbial metabolism as being re-
sponsible for the appearance of the water
soluble metabolites. Attempts to isolate
significant quantities of each major
metabolite by column chromatography on a
silicic acid gel were unsuccessful due to in-
sufficient separation, indicating that chem-
ically these compounds may be very similar.
Small quantities of three of the major
metabolites have been isolated by prepara-
tive thin layer chromatography. Ultraviolet
spectra of these materials in methanol gave
an absorption maximum between 277 and
280 nm for each compound, indicating a
similar conjugated framework in each. Mass
spectra of these compounds obtained at an
ionizing voltage of 80 eV gave a fragmenta-
tion pattern in which almost all the peaks
were below molecular weight 100. The only
generalization which can be made is that the
pattern is similar to that for compounds
containing a benzenoid ring structure.
Currently, attempts are being made to
separate the major metabolites by gas chro-
matography so that they can be charac-
terized by combined GC-mass spectral
analysis.
Summary
The experiments described in this paper
show that in rats intravenous DEHP dis-
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FIGURE 8. Radioactivity profile of a thin-layer
chromatograph of the water-soluble metabolites
extracted with chloroform from the acidified
urine of rats given an intravenous dose of
14C-labeled DEHP.
Environmental Health Perspectives 128appears rapidly from the bloodstream and is
localized primarily in the liver. This occurs
whether the DEHP is administered as a solu-
tion or as an emulsion. In addition, de-
pending upon the degree of emulsification,
varying amounts of DEHP can be found in
the lungs, ranging from less than 2% after 24
hr for finely emulsified preparations to
greater than 30%, with long-term retention,
for poorly emulsified preparations. Thus, the
clearance of DEHP by the pulmonary circu-
lation is highly dependent upon the dimen-
sions of the oil droplets presented to it. On
the other hand, clearance by the liver
appears to occur readily, independent of the
degree of emulsification. However, the
hepatic uptake process appears to be satu-
rated at a dose of 200 mg/kg as suggested
by the slower rate of disappearance of this
higher dose from the blood.
In addition, DEHP appears to be ex-
tensively metabolized by the rat to
water-soluble metabolites which are excreted
primarily in the urine and feces. Thus an
intravenous dose of 0.1 mg DEHP/kg of
body weight can be almost totally accounted
for as excreted water-soluble metabolites
within 24 hr of administration.
Following oral administration of 200
mg/kg, the metabolism of DEHP and excre-
tion of the metabolites are so rapid relative
to the rate of absorption of DEHP from the
gastrointestinal tract that no significant
quantities of DEHP can be found in the
blood or tissues. Finally, preliminary results
have shown that metabolism of DEHP by
the rat does not consist of simple stepwise
de-esterification of the dialkyl ester. Rather,
at least four chemically similar water-soluble
metabolites are formed.
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